Ringkjoebing Landbobank A/S (RILBA)
Nasdaq Copenhagen · Denmark · prices in DKK · close of 27 Oct 2026
Key indicators
| Last close | DKK 1,741.00 |
|---|---|
| 52-week range | 1,384.00 – 1,896.00 |
| Return, 1 month / 3 months | −5.2% / +0.8% |
| Return, 1 year / 3 years | +22.1% / +93.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 19.3% |
| Worst drawdown (1 year) | -11.6% |
| Average daily value traded | 50.39M DKK |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ringkjoebing Landbobank is a Danish bank based in the town of Ringkoebing. It serves private individuals, small and medium-sized businesses and agricultural customers, mainly in its home region and elsewhere in Denmark. Its services include deposit accounts, loans, mortgages, credit facilities, insurance products and wealth management, along with card and payment services. The bank also offers advisory services to personal and corporate clients through its local branches.
Ringkjoebing Landbobank A/S trades under the code RILBA on the Nasdaq Copenhagen in Denmark, with its price quoted in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ringkjoebing Landbobank A/S (RILBA) trades on the Nasdaq Copenhagen in Denmark. It last closed at DKK 1,741.00 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 34 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.1% and over the last three months it rose 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Copenhagen
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.1% | ||
| From 52-week high | -7.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.8% | ||
| 6-month return | 12.0% | ||
| 12-month return, skipping the last month | 28.8% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.6% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 50.39M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.7% |
|---|---|
| 1 month | −5.2% |
| 3 months | +0.8% |
| 6 months | +12.0% |
| 1 year | +22.1% |
| 3 years | +93.3% |
| 5 years | +121.1% |
Signals
| 50-day / 200-day average | 1,803.74 / 1,656.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 38.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Mar 2026 | DKK 12.0000 |
| 6 Mar 2025 | DKK 11.0000 |
| 29 Feb 2024 | DKK 10.0000 |
| 2 Mar 2023 | DKK 7.0000 |
| 3 Mar 2022 | DKK 7.0000 |
| 4 Mar 2021 | DKK 7.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Copenhagen; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.